Establishment of an Australian motor neurone disease registry [4]

Medical Journal of Australia

Volumn 184, Issue 7, 2006, Pages 367-368

  Kiernan, Matthew C ^a   Talman, Paul ^b   Henderson, Robert D ^c   Harris, Rodney ^d  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b GEELONG HOSPITAL   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d Motor Neurone Disease Association of Victoria   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; AWARENESS; DATA ANALYSIS; FOLLOW UP; HUMAN; LETTER; MEDICAL RESEARCH; MEDICAL SPECIALIST; MOTOR NEURON DISEASE; PATIENT INFORMATION; PHENOTYPE; REGISTER; REGISTRATION;

EID: 33645790821     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2006.tb00279.x     Document Type: Letter

References (5)

1. Kiernan MC. Riluzole: a glimmer of hope in the treatment of motor neurone disease. Med J Aust 2005; 182: 319-320.
2. Bradley WG, Anderson F, Bromberg M, et al. Current management of ALS: comparison of the ALS CARE database and the AAN practice parameter. The American Academy of Neurology. Neurology 2001; 57: 500-504.
3. Winhammar JM, Rowe DB, Henderson RD, Kiernan MC. Assessment of disease progression in motor neuron disease. Lancet Neurol 2005; 4: 229-238.
4. Talman P, Mathers S, Mostert E, Forbes A. Evaluation of clinical patterns and rate of progression of motor neuron disease. Amyotroph Lateral Scler Other Motor Neuron Disord 2002; 3: 93.
5. Talman P, Rowe D, Kiernan MC. Australian Motor Neurone Disease Registry (AMNDR). J Neurol Sci 2005; 238 Suppl 1: S214.